Varian Medical Systems (VAR) : Anchor Capital Advisors reduced its stake in Varian Medical Systems by 2.45% during the most recent quarter end. The investment management company now holds a total of 583,737 shares of Varian Medical Systems which is valued at $55,250,707 after selling 14,634 shares in Varian Medical Systems , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Varian Medical Systems makes up approximately 1.42% of Anchor Capital Advisors’s portfolio.
Other Hedge Funds, Including , Evercore Wealth Management reduced its stake in VAR by selling 425 shares or 29.82% in the most recent quarter. The Hedge Fund company now holds 1,000 shares of VAR which is valued at $94,650.Hartford Investment Management Co reduced its stake in VAR by selling 369 shares or 1.59% in the most recent quarter. The Hedge Fund company now holds 22,825 shares of VAR which is valued at $1,986,688. Varian Medical Systems makes up approx 0.04% of Hartford Investment Management Co’s portfolio. Americafirst Capital Management sold out all of its stake in VAR during the most recent quarter. The investment firm sold 8,102 shares of VAR which is valued $705,765.Loring Wolcott Coolidge Fiduciary Advisors Llpma reduced its stake in VAR by selling 140 shares or 46.67% in the most recent quarter. The Hedge Fund company now holds 160 shares of VAR which is valued at $13,822.Lau Associates reduced its stake in VAR by selling 700 shares or 12.07% in the most recent quarter. The Hedge Fund company now holds 5,100 shares of VAR which is valued at $433,449. Varian Medical Systems makes up approx 0.45% of Lau Associates’s portfolio.
Varian Medical Systems opened for trading at $94.63 and hit $95.21 on the upside on Thursday, eventually ending the session at $94.82, with a gain of 0.18% or 0.17 points. The heightened volatility saw the trading volume jump to 6,48,019 shares. Company has a market cap of $9,028 M.
On the company’s financial health, Varian Medical Systems reported $1.22 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $1.17. The company had revenue of $789.40 million for the quarter, compared to analysts expectations of $782.00 million. The company’s revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS.
Many Wall Street Analysts have commented on Varian Medical Systems. Company shares were Reiterated by Barrington Research on Jul 28, 2016 to “Outperform”, Firm has raised the Price Target to $ 102 from a previous price target of $93 .
Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy radiosurgery proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical scientific and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer taking X-ray images and protecting ports and borders. The Companys products include linear accelerators brachytherapy afterloaders treatment simulation and verification equipment accessories information management treatment planning and image processing software. The Companys customers include university research and community hospitals private and governmental institutions healthcare agencies doctors offices and cancer care clinics.